<DOC>
	<DOCNO>NCT01432717</DOCNO>
	<brief_summary>The purpose study find whether ACE-536 safely give patient . This study also look see ACE-536 increase red blood cell , cell carry oxygen body .</brief_summary>
	<brief_title>Study ACE-536 Healthy Postmenopausal Women</brief_title>
	<detailed_description />
	<criteria>Key Postmenopausal woman Body Mass Index ( BMI ) 20 32 kg/m2 . Key History hypertension Subject receive erythropoiesis stimulate agent ( e.g. , Epogen , Procrit , Aranesp , etc . ) within 6 month prior Day 1 History clinically significant cardiac , endocrine , hematologic , hepatic , immune , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , and/or disease Surgery within 3 month ( minor cosmetic surgery minor dental procedure ) Subject receive treatment another investigational drug , approve therapy investigational use within 1 month prior Day 1 , halflife previous product know , within 5 time halflife prior Day 1 , whichever long</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>